1. |
Dougherty TJ, Bugeski PJ, Porter CW. Autoradiographic distribution of hematoporphyrin derivetive in normal and tumor tissue of the mouse. Cancer Res, 1981; 41(12)∶4606.
|
2. |
Holyoke ED. New surgical approaches to pancreatic cancer. Cancer, 1981; 47(6)∶1719.
|
3. |
Moesta KT, Greco WR, NurseFinlay SO. Lack of reciprocity in drug and light dose dependence of photodynamic therapy of pancreatic adenocarcinoma in vitro. Cancer Res, 1995; 55(14)∶3078.
|
4. |
Fowler GJ, Rees RC, Devonshire R. The photokilling of bladder carcinoma cells in vitro by phenothiazine dyes. Photochem Photobiol, 1990; 52(3)∶489.
|
5. |
Ward AJ, Matthews EK. Cytotoxic, nuclear, and growth inhibitory effects of photodynamic drugs on pancreatic carcinoma cells. Cancer Letters, 1996; 102(1~2)∶39.
|
6. |
Cerytti P. Prooxidant states and tumor promotion. Science, 1985; 227(4685)∶375.
|
7. |
Ward AJ, Olive PL, Burr AH. A sensitivity to oxidative stress is linked to chromosome 11 but is not due to a difference in single strand DNA breakage or repair. Mutat Res, 1993; 294(3)∶299.
|
8. |
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 1983; 65(1~2)∶55.
|
9. |
Matthews EK, Cui IJ. Photodynamic action of sulphonated aluminium phothalocyanine (sALPc) on AR42J cells, a carcinoma cell line of rat exocrine pancreas. Br J Cancer, 1990; 61(5)∶695.
|
10. |
Ratcliffe SL, Matthews EK. Modification of the photodynamic action of deltaaminolaevulinic acid (ALA) on rat pancreatoma cells by mitochondrial benzodiazepine receptor ligands. Br J Cancer, 1995 FEB; 71(2)∶300.
|
11. |
Mang TS, Wieman TJ. Photodynamic therapy in the treatment of pancreatic carcinoma: dihematoporphyrin ether uptake and photobleaching kinetics. Photochem Photobiol, 1987; 46(5)∶853.
|
12. |
Tralau CJ, Barr H, Sandeman DR. Aluminium sulfonated phthalocyanine distribution in rodent tumors of the colon, brain and pancreas. Photochem Photobiol, 1987; 46(5)∶777.
|
13. |
Chatlani PT, Nuutinen PJO, Toda N. Selective necrosis in hamster pancreatic tumors using photodynamic therapy with phthalocyanine photosensitization. Br J Surg, 1992; 79(8)∶786.
|
14. |
Schroder T, MD, Chen, IW, PhD, Matthew S, BS. Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol, 1988; 38(1)∶4.
|
15. |
Aprahamian M, Evrard S, Keller P. Distribution of pheophorbide A in normal tissues and in an experimental pancreatic cancer in rats. Anticancer Drug Design, 1993; 8(2)∶101.
|
16. |
Evrard S, Keller P, Hajri A. Experimental pancreatic cancer in the rat treated by photodynamic therapy. Br J Surg, 1994; 81(8)∶1185.
|
17. |
Regula J, Ravi B, Bedwell J. Photocynamic therapy using 5aminolaevulinic acid for experimental pancreatic cancerprolonged animal survival. Br J Cancer, 1994; 70(2)∶248.
|
18. |
Bedwell J, Macrobert AJ, Phillips D. Fluorescence distribution and photodynamic effect of ALAinduced PPIX in the DMH rat colonic model. Br J Cancer, 1992; 65(6)∶818.
|
19. |
Van Hillegersberg R, Vandenberg JWO, Kort WJ. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology, 1992; 103(2)∶647.
|
20. |
Larroque CS, Pelegrin A, Van Lier JE Van. Serum albumin as a vehicle for zincphthalocyanine: photodynamic activities in solid tumor models. Br J Cancer, 1996; 74(12)∶1886.
|
21. |
Mew D, Lum V, Wat CK. Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation. Cancer Res, 1985; 45(9)∶4380.
|
22. |
Muller PJ, Wilson BC. Photodynamic therapy of malignant brain tumors. Can J Nrurol Sci, 1990; 17(2)∶193.
|